EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Innovative utilization of cell membrane‐coated nanoparticles in precision cancer therapy

Yiling He, Shuquan Zhang, Yaoguang She, Zhaoshan Liu, Yalan Zhu, Qinzhen Cheng, Xiaoyuan Ji iD

Exploration · 2024-12 · 4 (6)

DOI: 10.1002/exp.20230164 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Exploration, online erschienen am 21.03.2024. Verfasst von Yiling He und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Jinhua Municipal Central Hospital Jinhua Zhejiang China. Die Arbeit wurde bisher 115-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cell membrane‐coated nanoparticles (CMNPs) have recently emerged as a promising platform for cancer therapy. By encapsulating therapeutic agents within a cell membrane‐derived coating, these nanoparticles combine the advantages of synthetic nanoparticles and natural cell membranes. This review provides a comprehensive overview of the recent advancements in utilizing CMNPs as effective drug delivery vehicles for cancer therapy. The synthesis and fabrication methods of CMNPs are comprehensively discussed. Various techniques, such as extrusion, sonication, and self‐assembly, are employed to coat synthetic nanoparticles with cell membranes derived from different cell types. The cell membrane coating enables biocompatibility, reducing the risk of an immune response and enhancing the stability of the nanoparticles in the bloodstream. Moreover, functionalization strategies for CMNPs, primarily chemical modification, genetic engineering, and external stimuli, are highlighted. The presence of specific cell surface markers on the coated membrane allows targeted drug delivery to cancer cells and maximizes therapeutic efficacy. Preclinical studies utilizing CMNPs for cancer therapy demonstrated the successful delivery of various therapeutic agents, such as chemotherapeutic drugs, nucleic acids, and immunotherapeutic agents, using CMNPs. Furthermore, the article explores the future directions and challenges of this technology while offering insights into its clinical potential.

Schlagwörter

Stichwörter der Autor:innen

cancer therapycell membrane‐coated nanoparticlesnanomaterialstargeted drug delivery

Autor:innen und Institutionen

  • Department of Pharmacy Jinhua Municipal Central Hospital Jinhua Zhejiang China.
  • Department of Orthopedics Integrated Chinese and Western Medicine Hospital Tianjin University Tianjin China.
  • Department of Orthopedics Tianjin Nankai Hospital Tianjin China.
  • Department of Orthopedics Tianjin Hospital of Integrated Chinese and Western Medicine Tianjin China.
  • Department of General Surgery First Medical Center Chinese People's Liberation Army (PLA) General Hospital Beijing China.
  • Laboratory of Immune Cell Biology Center for Cancer Research National Cancer Institute National Institutes of Health Bethesda Maryland USA.

ORCID-Profile: Xiaoyuan Ji

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

He, Y., Zhang, S., She, Y., Liu, Z., Zhu, Y., Cheng, Q., & Ji, X. (2024). Innovative utilization of cell membrane‐coated nanoparticles in precision cancer therapy. Exploration, 4(6). https://doi.org/10.1002/exp.20230164

Vancouver

He Y, Zhang S, She Y, Liu Z, Zhu Y, Cheng Q, et al. Innovative utilization of cell membrane‐coated nanoparticles in precision cancer therapy. Exploration. 2024;4(6). doi:10.1002/exp.20230164

BibTeX
@article{He2024,
  author = {He, Yiling and Zhang, Shuquan and She, Yaoguang and Liu, Zhaoshan and Zhu, Yalan and Cheng, Qinzhen and Ji, Xiaoyuan},
  title = {Innovative utilization of cell membrane‐coated nanoparticles in precision cancer therapy},
  journal = {Exploration},
  year = {2024},
  volume = {4},
  number = {6},
  doi = {10.1002/exp.20230164}
}
Kostenlos starten →